All Type of News
Scarcity of senior influenza vaccines in private medical institutions
Although influenza vaccination for seniors has been enforced at no cost since the 1st this month, some private medical institutions are experiencing difficulties due to insufficient vaccine provision and the leaning p...
The great Baraclude generic war with price or marketing power
As the patent of ‘Baraclude(generic name: entecavir, BMS Pharmaceutical Korea), a chronic hepatitis B treatment, will be expired on 9th of October, a great generic war will begin.
Baraclude is a product recording the...
New drug development of Dong-A ST’s Suganon TabThe Ministry of Food and Drug Safety(Minister Seung-hee Kim, MFDS) announced approval of ‘Suganon Tab,’ a Dong-A ST’s new drug developed in the domestic industry, on the 2nd of ...
|
AstraZeneca’s Seroquel will be sold by Alvogen Korea from 9th
‘Seroquel’ and ‘Seroquel XR Tab’ which are currently sold by AstraZeneca Korea are expected to be sold and distributed by Alvogen Korea from the coming 9th.
According to the industry concerned on the 2nd, AstraZeneca...
The Differential Medical Fee System to become history
As the Differential Medical Fee System, which has continuously been criticized to be abolished in the 17th, 18th and 19th National Inspections of the National Assembly, was decided to be abolished by the Health Insura...
Will Boehringer Ingelheim’s ‘nintedanib’ become a victim of the risk sharing system?
As Ildong Pharmaceutical’s idiopathic pulmonary fibrosis(IPF) treatment, ‘Pirespa(generic name: pirfenidone)’ has acquired the health insurance application, its follow-up substance, Boehringer Ingelheim’s nintedanib, ...
Impossibility to export biosimilar drug price at 30% of foreign prices
In order for biopharmaceutical products, which have been chosen as a new growth industrial power by the government, to have expansion and leadership in the global market, the biopharmaceutical industry has raised a st...
Listed pharmaceutical companies’ market capitalization evaporated by KRW 11.64 trillion in 3 months
As the bubble in pharmaceutical and biopharmaceutical stocks has been controversy in the second half of the year, it was observed market capitalizations of domestic listed pharmaceutical companies(including biopharmac...
2014 pharmaceutical market increased in export, but remained in average annual growth rate
Exports were slightly increased in the pharmaceutical market in 2014, but its growth rate was about the same compared to the year before.
According to the ‘2015 Annual Report of Food and Drug Statistics’ of the Minis...
Pfizer’s ERP recruitment completedThe Pfizer’s Early Retirement Program(ERP) problem has been temporarily settled.
According to the industry concerned on the 2nd, Pfizer Korea finished the recruitment of ERP ca...
|
